• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    IDEX Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

    5/12/25 1:07:05 PM ET
    $IEX
    Fluid Controls
    Industrials
    Get the next $IEX alert in real time by email
    iex-20250508
    0000832101false00008321012025-05-082025-05-08

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of The
    Securities Exchange Act of 1934
    Date of Report: May 8, 2025
    (Date of earliest event reported)
    IDEX CORPORATION
    (Exact name of registrant as specified in its charter)
    Delaware1-1023536-3555336
    (State or other jurisdiction (Commission File Number)(IRS Employer
    of incorporation)Identification No.)
    3100 Sanders Road, Suite 301
    Northbrook, Illinois 60062
    (Address of principal executive offices, including zip code)
    (847) 498-7070
    (Registrant’s telephone number, including area code)
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $.01 per shareIEXNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 5.07 – Submission of Matters to a Vote of Security Holders.

    On May 8, 2025, IDEX Corporation (the "Company") held its Annual Meeting of Stockholders and voted on the following matters:

    1.The election of three Class III directors to serve a three-year term. Eric D. Ashleman, Stephanie J. Disher and Matthijs Glastra were elected to serve as Class III directors for a three-year term expiring at the Company’s annual meeting to be held in 2028, or upon the election and qualification of their successors.

    DirectorForAgainstAbstentions Broker Non-Votes
    Eric D. Ashleman67,244,543 507,156 13,516 1,718,378 
    Stephanie J. Disher64,404,974 3,347,060 13,181 1,718,378 
    Matthijs Glastra66,210,483 1,541,197 13,535 1,718,378 

    2.A proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers. The proposal received the affirmative vote of a majority of the shares present in person or represented by proxy and entitled to vote on the matter as follows:

    Affirmative Votes59,216,982 
    Negative Votes7,714,378 
    Abstentions833,855 
    Broker Non-Votes1,718,378 

    3.A proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for 2025. The proposal received the affirmative vote of a majority of the shares present in person or represented by proxy and entitled to vote on the matter as follows:
             
    Affirmative Votes60,637,663 
    Negative Votes8,839,575 
    Abstentions6,355 


    4.A stockholder proposal to approve a report on hiring practices related to people with arrest or incarceration records. The proposal did not receive the affirmative vote of a majority of the shares present in person or represented by proxy and entitled to vote on the matter as follows:
             
    Affirmative Votes9,437,823 
    Negative Votes55,577,864 
    Abstentions2,749,528 
    Broker Non-Votes1,718,378 






    Item 9.01 – Financial Statements and Exhibits.

    (d)    Exhibits

    104    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).




    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
                                      IDEX CORPORATION
    By:/s/ ABHISHEK KHANDELWAL
    Abhishek Khandelwal
    Senior Vice President and Chief Financial Officer
    May 12, 2025

    Get the next $IEX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $IEX

    DatePrice TargetRatingAnalyst
    8/14/2024Buy → Hold
    Argus
    2/8/2024$215.00 → $265.00Hold → Buy
    Stifel
    10/5/2023$200.00Neutral
    Exane BNP Paribas
    7/18/2022$229.00 → $188.00Buy → Hold
    Stifel
    7/14/2022$215.00Perform → Outperform
    Oppenheimer
    3/9/2022Market Perform → Outperform
    Cowen & Co.
    3/9/2022$220.00Market Perform → Outperform
    Cowen
    1/11/2022$230.00Market Perform
    Bernstein
    More analyst ratings